FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB4 days ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
FTC Deepens Inquiry into Prescription Drug Middlemen
WEBMay 17, 2023 · As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issu.
Federal Trade Commission sues largest drug middlemen for
WEB4 days ago · CNN —. The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
WEBJul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug costs...
Pharmacy benefit managers profit at expense of patients and small ... - CNN
WEBJul 9, 2024 · Pharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of millions of Americans, are racking up profits while squeezing patients and independent...
FTC to sue PBMs over drug prices including insulin, source says
WEBJul 10, 2024 · Six of the largest PBMs handled nearly 95% of the prescriptions filled in the U.S., the FTC’s report said. PBMs contend that manufacturers are responsible for high drug prices, while drugmakers...
FTC's lawsuit against 'behemoth PBMs': What to know
WEB9 hours ago · FTC files lawsuit against top PBMs and GPOs for alleged anticompetitive practices in inflating insulin prices. Learn about the allegations and responses.
ANALYSIS: FTC Joins States to Curb Drug Middlemen Power
WEB1 day ago · The Federal Trade Commission’s lawsuit against three of the top pharmacy benefit managers (PBMs) on Sept. 20 is the first important step the federal government has taken to try to curb the power of PBMs. With little federal action, almost half the states have enacted legislation this year to try and combat high consumer drug costs, high PBM control in pricing negotiations, and high profits ...
FTC sues PBMs, affiliated GPOs for inflating insulin prices
WEB1 day ago · FTC sues PBMs, affiliated GPOs for inflating insulin prices. Caremark Rx, Express Scripts, and OptumRx are facing legal repercussions after the FTC accused them of insulin price inflation in a lawsuit announced on Sept. 20, 2024. Caremark Rx, Express Scripts, Optum Rx and their affiliated group purchasing organizations are being accused by …
Skip to content